A GIC official said last November that the agency determined that using a vendor to manage GLP-1 drugs for weight loss more closely was the most responsible next step to achieve savings and maintain GIC coverage for GLP-1s for weight loss. Zucchi called the new program infuriating because hes been treating patients, like state employee Deb LaValle, for several years with obesity medications
Fact: NAC is a building block (precursor), while glutathione is the final product
Its only controlled human trial a Phase II study for postoperative ileus failed its primary endpoint , and clinical development was discontinued [5]
10.1371/journal.pone.0025269 130 ShiY.TaherifardE.SaeedA.SaeedA
attempted to determine the immunomodulatory effects of gene expression like AP5Z1 after finding almost no significant change on inflammatory parameters (10)
Mustapic M, Eitan E, Werner JK Jr., Berkowitz ST, Lazaropoulos MP, Tran J, et al